Crewe Advisors’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-196
Closed -$4.41K 1008
2023
Q1
$4.41K Hold
196
﹤0.01% 647
2022
Q4
$4.12K Hold
196
﹤0.01% 708
2022
Q3
$5K Hold
196
﹤0.01% 863
2022
Q2
$5K Buy
+196
New +$5K ﹤0.01% 778